MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
-$18,476K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Accrued expenses and other curre...
    • Change in fair value of warrant ...
    • Amortization of operating lease ...
    • Employee stock purchase plan com...
Negative Cash Flow Breakdown
    • Net loss
    • Prepaid expenses
    • Accounts payable
    • Others
Cash Flow
2025-09-30
2025-06-30
Net loss
-18,990
-43,155
Stock-based compensation expense
1,142
3,587
Amortization of insurance premium
0
0
Amortization of operating lease right-of-use assets
111
213
Amortization of leasehold improvements
0
1
Change in operating lease liability
-102
-193
Change in fair value of warrant liabilities
2,369
-4,541
Prepaid expenses
15,619
-158
Accounts payable
-135
428
Accrued expenses and other current liabilities
12,823
-5,475
Other liabilities
0
0
Net cash used in operating activities
-18,401
-48,977
Net cash provided by investing activities
0
0
Proceeds from issuance of common stock, net of issuance costs
-1
-
Employee stock purchase plan common stock issuance
20
-
Restricted stock units released settlement of payroll taxes
94
-
Repayments of short-term borrowings
0
0
Exercise of common warrants
0
0
Exercise of stock options
0
0
Proceeds from issuance of common stock and pre-funded warrants, net of issuance costs
-
0
Net cash (used) provided by financing activities
-75
0
Net (decrease) increase in cash and cash equivalents
-18,476
-48,977
Cash and cash equivalents at beginning of period
79,398
-
Cash and cash equivalents at end of period
11,945
-
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net (decrease)increase in cash and cash...-$18,476K Accrued expenses andother current...$12,823K Change in fair value ofwarrant liabilities$2,369K Stock-based compensationexpense$1,142K Amortization of operatinglease right-of-use...$111K Employee stock purchaseplan common stock...$20K Net cash used inoperating activities-$18,401K Net cash (used)provided by financing...-$75K Canceled cashflow$16,445K Canceled cashflow$20K Net loss-$18,990K Restricted stock unitsreleased settlement of...$94K Prepaid expenses$15,619K Accounts payable-$135K Change in operatinglease liability-$102K Proceeds from issuance ofcommon stock, net of...-$1K

Applied Therapeutics, Inc. (APLT)

Applied Therapeutics, Inc. (APLT)